Proud to present a recent collaboration with Immunocine Cancer Center!

I am thrilled to share with you this patient information graphic, designed to provide a visual understanding of Immunocine's groundbreaking Dendritic Cell Treatment for cancer.

What sets Immunocine's approach apart is their innovative technique called "Double Loading" of a patient's Dendritic Cells.

While other Dendritic Cell Treatments solely focus on internal or external loading of these cells, Immunocine takes a dual approach by doing both simultaneously. This unique methodology results in a robust Th1 immune response, activating Killer T cells to target and combat the patient's cancer.

By synergizing cutting-edge science and clinical expertise, Immunocine is revolutionizing the field of cancer immunotherapy.

This ground-breaking treatment holds immense promise for patients, offering a new ray of hope in the fight against cancer.

I am honored to be part of this collaborative effort, bringing together a team of passionate professionals dedicated to improving patient outcomes and making a lasting impact in the battle against cancer.

©Kotryna Zukauskaite, 2023